Europe — EMA
Montelukast Sandoz
GNH USA supplies Montelukast Sandoz (Montelukast), a leukotriene receptor antagonist for asthma and allergic rhinitis. Request a quote for global supply.
Request sourcing
What is Montelukast?
Montelukast, the active ingredient in Montelukast Sandoz, is a leukotriene receptor antagonist presented as a tablet for oral use. It treats asthma, allergic rhinitis and exercise‑induced bronchoconstriction in adults and children.
GNH USA supplies Montelukast Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Montelukast used for?
Montelukast acts on the leukotriene pathway to control chronic respiratory conditions.
Asthma (maintenance therapy): Reduces the frequency of asthma attacks and improves lung function. Allergic rhinitis: Alleviates nasal congestion, sneezing and itching associated with seasonal allergies. Exercise‑induced bronchoconstriction: Prevents narrowing of the airways triggered by physical activity.
What are the side effects of Montelukast?
Montelukast may cause a range of adverse reactions, varying from mild to serious.
Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: occasional discomfort. - Cough: transient irritation. - Nausea: occasional upset stomach.
Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or anaphylaxis. - Neuropsychiatric events: agitation, depression, suicidal thoughts. - Hepatic injury: rare cases of elevated liver enzymes or hepatitis.
What precautions apply to Montelukast?
Montelukast requires careful consideration in several clinical situations.
Pregnancy: Use only if clearly needed, as safety data are limited. Breastfeeding: Caution, drug may be excreted in milk. Liver impairment: Monitor liver function; dosage adjustment may be required. Concomitant enzyme inducers (e.g., phenobarbital, rifampin): May reduce effectiveness. Store at ambient temperature: Keep below 25 °C, retain original packaging and protect from moisture.
What does Montelukast interact with?
Montelukast can interact with other medicines that affect its metabolism or therapeutic outcomes.
Major Interactions (Avoid): - Phenobarbital, carbamazepine, rifampin: Induce metabolism, decreasing drug levels. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): May increase exposure.
Moderate Interactions (Monitor Closely): - Warfarin: May enhance anticoagulant effect; monitor INR. - Theophylline: Potential alteration of plasma concentrations. - Beta‑agonists: No direct interaction, but monitor overall asthma control.
Frequently asked questions
What is Montelukast Sandoz used for?+
How does Montelukast work?+
What is the usual dose of Montelukast?+
Is Montelukast safe in pregnancy or breastfeeding?+
How do I order Montelukast Sandoz from GNH USA?+
How does Montelukast compare with other asthma treatments?+
How should Montelukast be stored and handled?+
How is Montelukast administered?+
What are the most serious risks to watch for while taking Montelukast?+
Who should not use Montelukast?+
Product details
Related products

MONTELUKAST SODIUM 5 mg/1
Montelukast · 5 mg

MONTELUKAST SODIUM 5 mg/1
Montelukast · 5 mg

Montelukast 10 mg/1
Montelukast · 10 mg

Montelukast 10 mg/1
Montelukast · 10 mg